http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111521706-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2582f1b64b97123fdfa087046f793a9c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-045
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02
filingDate 2020-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_474b15583ddc7378935fd9e37acf85ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a86d6f9cddfb97bdd6342c6915be353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bb16c8fd368db5fbd6bdcdfd772c50b
publicationDate 2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111521706-A
titleOfInvention A method for rapid detection of cefixime concentration in plasma
abstract The invention discloses a method for rapidly detecting the concentration of cefixime in plasma. In a 96-well plate, LC-MS/MS analysis was performed; (2) Chromatographic separation: an aqueous solution containing 0.1% formic acid and 5 mM ammonium acetate was used as mobile phase A, and acetonitrile containing 0.5% formic acid was used as mobile phase B. A: Mobile phase B=50:50; isocratic elution, elution time 2.4min; (3) mass spectrometry detection. The detection method of the invention has high sensitivity, and the lowest concentration that can be quantified can reach 10.00 ng/mL. The invention is suitable for use in the bioequivalence of cefixime capsules or human pharmacokinetic research.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112903849-A
priorityDate 2020-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103889224-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451483411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407631466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457797993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121225283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18373917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451679761
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453148806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6321411

Total number of triples: 30.